SHP2 Inhibitors for Autoimmune Diseases
Overview:
Tyrosine phosphatase SHP2 inhibitors for the treatment of various autoimmune and inflammatory diseases.
Status:
Purdue Faculty:
Research Articles:
Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus